Q1 provided few surprises: total orders were a touch better than expected; orders received margins continued to decline; China orders matched our estimates; cash flow was strong; and the 2025 guidance was broadly in line with consensus. Having raised our 2025–2027e clean EPS by c2% on average, we have increased our target price to EUR55 (52) but reiterate our HOLD.
Helped by still-solid core revenues and firm cost efficiency, PARB reported a Q1 ROE of 13.5%, despite some provisions. With deposit volumes rising by ~8.1% QOQ, the bank somewhat increased its bond holdings in the quarter, resulting in a ~5bp lower CET1 ratio at quarter-end, offset by strong earnings generation. We have made only minor changes to our 2026–2027e EPS. With the stock trading at a 2026e P/E of ~8.0x, we still find the valuation attractive, and reiterate our BUY and NOK84 target pri...
With elevated margin pressure and higher costs YOY, Q1 ROE was 11.2%, despite modest loan losses. Given the composition of the lending growth, MORG increased its risk-weight assets, leading to a ~ 20bp lower CET1 ratio QOQ. That said, the bank guided for a net positive effect of ~1.5%-points from the pending implementation of Basel IV in Q2 and Q3, leaving an ample buffer to its 16.15% requirement (including P2G), boding well for solid distributions. We have lowered our 2026–2027e EPS by ~5% on ...
A director at Gjensidige Forskring ASA bought 1,000 shares at 236.000NOK and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
On the back of repricing measures, mild winter weather, and a solid investment result, Gjensidige reported Q1 PTP of NOK1,719m, up ~60% YOY. Although we expect continued solid growth momentum on further price hikes of upwards of 19.5% in Private, the profitability focus is leading to some churn among Commercial clients. In sum, we have cut our 2026–2027e EPS by 1–2%, and reiterate our HOLD and NOK235 target price.
Two Directors at Investor AB bought 13,980 shares at between 282.400SEK and 286.790SEK. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.